Earnings call: Fulgent Genetics posts $70 million Q4 revenue

Published on 29 Feb 2024 on Investing.com

Fulgent Genetics (NASDAQ: NASDAQ: FLGT ) has reported a total revenue of $70 million for the fourth...

Read the rest of the article

Start tracking your investments with Statfolio

Fulgent Genetics, Inc. (NASDAQ:FLGT), is not the largest company out there, but it saw significan...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

Key Insights Institutions' substantial holdings in Fulgent Genetics implies that they have...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript May 3, 2024 Fulgent Genetic...

Insider Monkey via Yahoo Finance 5 May 2024

Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.01 per share versus the Zacks ...

Zacks via Yahoo Finance 3 May 2024

Key Insights The projected fair value for Fulgent Genetics is US$33.29 based on 2 Stage Free Cash...

Simply Wall St. via Yahoo Finance 1 Mar 2024

Fulgent Genetics (NASDAQ: NASDAQ: FLGT ) has reported a total revenue of $70 million for the four...

Investing.com 29 Feb 2024

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript February 28, 2024 Fulgent G...

Insider Monkey via Yahoo Finance 29 Feb 2024

Total Revenue: $289.2 million for the full year; $70.5 million for Q4 2023.Core Revenue Growth: U...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Conse...

Zacks via Yahoo Finance 27 Feb 2024

Fulgent Genetics Inc (NASDAQ:FLGT) reports Q3 2023 total revenue of $85 million, with core revenu...

GuruFocus.com via Yahoo Finance 6 Nov 2023